AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2017
Sep 20, 2017
35599_dirs_2017-09-20_38bf1f4d-9baa-4efc-9e31-ea2132fbca27.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2017-09-11
Reporting Person: Andrade Robert (Chief Financial Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $2.43 | 2018-08-18 | Common shares (323961) | Direct | |
| Stock Option (right to buy) | $1.89 | 2018-08-18 | Common shares (17050) | Direct | |
| Stock Option (right to buy) | $2.45 | 2023-07-05 | Common shares (75000) | Direct | |
| Stock Option (right to buy) | $5.10 | 2024-06-27 | Common shares (50000) | Direct |
Footnotes
F1: Item is in Canadian dollars.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20